Role of carnoy’s solution in the treatment of keratocystic odontogenic tumor: a systematic review

Álvaro Díaz-Belenguer ^[2] ; Alba Sánchez-Torres ^[1] ; Cosme Gay-Escoda ^[3]
1. [1] Universitat de Barcelona
  
  Universitat de Barcelona
  
  Barcelona, España
2. [2] DDS. Fellow of the Master’s Degree Program in Oral Surgery (EHFRE International University/FUCSO)
3. [3] MD, DDS, MS, PhD, EBOS. Chairman and Professor of the Oral and Maxillofacial Surgery Department, School of Dentistry, University of Barcelona. Director of Master’s Degree Program in Oral Surgery and Implantology (EHFRE International University/FUCSO). Coordinator/Researcher of the IDIBELL Institute. Head of Oral and Maxillofacial Surgery and Implantology Department of the Teknon Medical Center, Barcelona, Spain
Mostrar afiliaciones +
Localización: Medicina oral, patología oral y cirugía bucal. Ed. inglesa, ISSN-e 1698-6946, Vol. 21, Nº. 6 (Noviembre), 2016
Idioma: inglés
Enlaces
- Texto completo

Resumen
- The keratocystic odontogenic tumor is a benign but aggressive neoplasm. As enucleation alone obtains high recurrence rates, some adjuvant treatments such as Carnoy’s solution have been proposed. The aim of this study is to evaluate the reduction of recurrences with the use of Carnoy’s solution as adjuvant in the treatment of keratocystic odontogenic tumors.
  
  All the studies included were case series. The recurrence rate of enucleation ranged from 0% to 58.8%. With the only use of Carnoy’s solution as adjuvant treatment to the enucleation, recurrences varied from 0% to 100%. The use of ≥ 2 adjuvant treatments reduced the range between 0% and 7.9%.
  
  The use of Carnoy’s solution as adjuvant therapy for the treatment of keratocystic odontogenic tumor has a grade C recommendation.